Stay updated on ValueofDapagliflozininHFpEF ClinicalTrial

Sign up to get notified when there's something new on the ValueofDapagliflozininHFpEF ClinicalTrial page.
Latest website image capture
Clouds background image

Latest updates to the ValueofDapagliflozininHFpEF ClinicalTrial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:11:28.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of a study related to the effects of Dapagliflozin on cardiovascular Cardiomyopathy, morbidity, and mortality in patients with type 2 diabetes and heart failure with reduced ejection fraction.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:48.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. It now also includes a general description of eligibility criteria and a link to learn more about clinical studies.
    Difference
    8%
    Check dated 2024-05-22T21:35:54.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T23:25:28.000Z thumbnail image

Stay in the know with updates to ValueofDapagliflozininHFpEF ClinicalTrial

Enter your email address, and we'll notify you when there's something new on the ValueofDapagliflozininHFpEF ClinicalTrial page.